Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1843 1
1922 1
1923 1
1928 1
1930 1
1934 1
1941 1
1943 2
1950 1
1975 1
1994 1
2004 1
2006 2
2007 3
2008 3
2009 1
2010 2
2011 1
2012 3
2013 3
2014 2
2015 2
2016 2
2017 3
2018 5
2019 3
2020 9
2021 10
2022 9
2023 10
2024 9
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Introduction.
Camprodon JA, Barbour T. Camprodon JA, et al. Among authors: barbour t. Harv Rev Psychiatry. 2023 May-Jun 01;31(3):97-100. doi: 10.1097/HRP.0000000000000368. Harv Rev Psychiatry. 2023. PMID: 37171470 No abstract available.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: barbour t. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology.
Trapp NT, Purgianto A, Taylor JJ, Singh MK, Oberman LM, Mickey BJ, Youssef NA, Solzbacher D, Zebley B, Cabrera LY, Conroy S, Cristancho M, Richards JR, Flood MJ, Barbour T, Blumberger DM, Taylor SF, Feifel D, Reti IM, McClintock SM, Lisanby SH, Husain MM; National Network of Depression Centers Neuromodulation Task Group. Trapp NT, et al. Among authors: barbour t. Clin Neurophysiol. 2025 Feb;170:206-233. doi: 10.1016/j.clinph.2024.12.015. Epub 2024 Dec 19. Clin Neurophysiol. 2025. PMID: 39756350 Free article. Review.
Corrigendum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2020;97:1287-1296.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: barbour t. Kidney Int. 2021 May;99(5):1244. doi: 10.1016/j.kint.2021.03.008. Kidney Int. 2021. PMID: 33892867 Free article. No abstract available.
A Radiation Oncology Board Exam of ChatGPT.
Barbour AB, Barbour TA. Barbour AB, et al. Among authors: barbour ta. Cureus. 2023 Sep 1;15(9):e44541. doi: 10.7759/cureus.44541. eCollection 2023 Sep. Cureus. 2023. PMID: 37790062 Free PMC article.
Sex-specifics of ECT outcome.
Blanken MAJT, Oudega ML, Hoogendoorn AW, Sonnenberg CS, Rhebergen D, Klumpers UMH, Van Diermen L, Birkenhager T, Schrijvers D, Redlich R, Dannlowski U, Heindel W, Coenjaerts M, Nordanskog P, Oltedal L, Kessler U, Frid LM, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Bolwig T, Emsell L, Sienaert P, Bouckaert F, Abbott CC, Péran P, Arbus C, Yrondi A, Kiebs M, Philipsen A, van Waarde JA, Prinsen E, van Verseveld M, Van Wingen G, Ten Doesschate F, Camprodon JA, Kritzer M, Barbour T, Argyelan M, Cardoner N, Urretavizcaya M, Soriano-Mas C, Narr KL, Espinoza RT, Prudic J, Rowny S, van Eijndhoven P, Tendolkar I, Dols A. Blanken MAJT, et al. Among authors: barbour t. J Affect Disord. 2023 Apr 1;326:243-248. doi: 10.1016/j.jad.2022.12.144. Epub 2023 Jan 9. J Affect Disord. 2023. PMID: 36632848
Update on C3 glomerulopathy.
Barbour TD, Ruseva MM, Pickering MC. Barbour TD, et al. Nephrol Dial Transplant. 2016 May;31(5):717-25. doi: 10.1093/ndt/gfu317. Epub 2014 Oct 17. Nephrol Dial Transplant. 2016. PMID: 25326473 Free PMC article. Review.
Erratum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment" Kidney Int. 2020;97:1287-1296.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: barbour t. Kidney Int. 2020 Dec;98(6):1621. doi: 10.1016/j.kint.2020.11.001. Kidney Int. 2020. PMID: 33276869 Free article. No abstract available.
Psychiatric Applications of Repetitive Transcranial Magnetic Stimulation.
Marder KG, Barbour T, Ferber S, Idowu O, Itzkoff A. Marder KG, et al. Among authors: barbour t. Focus (Am Psychiatr Publ). 2022 Jan;20(1):8-18. doi: 10.1176/appi.focus.20210021. Epub 2022 Jan 25. Focus (Am Psychiatr Publ). 2022. PMID: 35746935 Free PMC article. Review.
86 results